Health, life science groups line up solidly behind Indy Pride Festival
With just a few exceptions, Indianapolis’ life sciences and health care community is turning out in force for the festival, with sponsorships, exhibit booths and parade units.
With just a few exceptions, Indianapolis’ life sciences and health care community is turning out in force for the festival, with sponsorships, exhibit booths and parade units.
The Indianapolis-based drugmaker has updated the label on Verzenio with a new warning after Japanese health officials said the drug is suspected of adversely affecting patients’ lungs.
The Irvington landmark has reopened as a multi-tenant space. Also this week: 10th Street Diner, Turn 3 Chicken & Waffles, Jailbird, Tiny House Treats, DeBella’s Subs and more.
Panelists from a broad range of life sciences fields shared their insights on key issues during IBJ's Life Sciences Power Breakfast on May 3.
Backed by more than $100 million in funding from Indiana companies and foundations, the Indiana Biosciences Research Institute has hired 39 employees and hopes to ramp up to 80 within another three years.
Reporter John Russell won four awards, while the newspaper’s art team swept the Page 1 design category, at the Best in Indiana competition hosted by the Indiana Professional Chapter of the Society of Professional Journalists.
AgriNovus Indiana’s Ag+Bio+Science Startup Showcase is growing faster than a corn stalk in June.
In its third year, the showcase attracted a record number of attendees, sponsors and participants for its pitch contest.
This month, Saxton took on an additional position—vice president for business development at Regenstrief Institute, a medical-research organization based in Indianapolis.
Long a leader in diabetes and neuroscience drugs, Eli Lilly and Co. is pushing hard and spending record sums to turbocharge its oncology business, potentially a huge growth area.
Dr. Rainer Fischer is giving up the roles of CEO and chief scientific officer, but will continue as senior executive for innovation and discovery.
The Indianapolis-based broadband provider raised the funds from some of its member-owners and a new owner: Wabash Valley Power.
The Indianapolis-based drugmaker could spend more than a half-billion dollars under a licensing deal with ImmuNext of New Hampshire to identify and commercialize a new antibody for immune diseases.
More than 20 years after founding his tech consulting and development firm Studio Science, Kristian Andersen has sold the company to a group of investors led by CEO Steve Pruden.
A new section—titled “Impact Indiana, the intersection of business and community”—makes its debut in this week’s IBJ and will focus on the role businesses and their leaders play in public-policy advocacy, volunteerism and neighborhood development.
Darcy Lee said girls know more about tech than they ever have. Still, the number of women in STEM-related careers hasn’t budged much.
A new study by BioCrossroads and Indiana University shows the sector’s economic impact grew about 1 percent last year, to $79 billion.
More than 20 CEOs from some of the biggest companies in Indiana sent a letter to top Republican lawmakers Wednesday urging them to restore a list of victim characteristics in bias-crimes legislation being considered by the Indiana General Assembly.
AgriNovus working to help Indiana capitalize on natural strengths.
Spark Therapeutics Inc. will give Roche Holding a chance to make up ground in a field where single treatments may command more than $1 million. It also snaps up an asset that rivals like Novartis might have coveted.